Focus on the "2024 CBA-China Annual Meeting" thousands of important guests gathered in Suzhou to celebrate the grand event!

The first CBA-China Annual Meeting of the Chinese American Association for Biomedical Science and Technology will be held at Suzhou International Expo Center on June 28-29, 2024. The conference brought together more than 20,000 delegates, more than 1,100 domestic and foreign guest speakers, and set up more than 90 theme forums, aiming to promote comprehensive exchanges between Chinese and American medical professionals, and provide a good environment for the development and cooperation of biopharmaceutical companies and scientific research institutions.
Dr. Yongbin Zhang, Vice President and Chief Technology Officer of Beijing Zhaoyan New Drug Research Center Co., Ltd. was invited to attend the conference, including participating in the "Closed-door Exchange Meeting on Global Development Strategy and Path of Innovative Drugs" as a representative of the former FDA review officer, and sharing the theme content of "Evaluation of non-clinical Elements of Clinical Development of Innovative Drugs" in the 12 "Clinical Areas" in the sub-venue. Introduce in detail the company's solutions in the whole life cycle of drugs, welcome industry colleagues to come to exchange and negotiate.

About CBA
ChineseBiopharmaceutical Association-USA,
Founded in 1995, CBA is the largest Chinese biomedical professional and technical association in the United States.
The primary purpose of the CBA is to serve as a bridge between the United States and China in the field of biomedicine, to promote comprehensive exchanges between Chinese and American medical professionals, and to provide a favorable environment for the development and cooperation of biopharmaceutical companies and scientific research institutions.
CBA members come from emerging technology companies in the United States and China, multinational pharmaceutical companies, universities, scientific research institutions, government medical processing departments, various research or industrial development support funds, legal and intellectual property professional organizations. More than 80% of CBA members have doctorates.
CBA has a good reputation in the world, with members all over the world, including China, the United States, Europe, Canada, Australia, Singapore and Japan. At present, the total number of individual members is more than 10,000, and the total number of corporate members is more than 1,000.
The CBA has a close relationship with the US Food and Drug Administration (FDA), and many of its presidents have worked in the FDA and are familiar with rules such as the international biomedical registration strategy. In particular, the University of Maryland has a close relationship with Hopkins University and the School of Medicine, and Jiangsu Province and Maryland are also sister provinces.